http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005123612-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 |
filingDate | 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2aaca52e6dd8d366bcefecada3b5597 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831400a9307d092ea8e6b246c72bbae0 |
publicationDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2005123612-A1 |
titleOfInvention | Ribavirin granulate for producing coated tablets |
abstract | The present invention relates to a method for the production of a ribavirin-containing granulate, comprising the production of a granulate solution, comprising mixing of a binding agent with an isopropanol/water- or ethanol/water-mixture, stirring of the granulate solution into a mixture of ribavirin-powder with a hydrophilic or swellable solid adjuvant, and sieving and drying the so-obtained granulate, which is characterised in that the portion of isopropanol or ethanol of the alcohol/water-mixture is between 65% to 85% by weight. Based on this granulate, a ribavirin-tablet can be produced that can be used for the treatment of diseases, such as HCV. |
priorityDate | 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.